Tumor progression and angiogenesis: Cathepsin B & Co

Biochemistry and Cell Biology

Volumn 74, Issue 6, 1996, Pages 799-810

  Keppler, Daniel ^a   Sameni, Mansoureh ^a   Moin, Kamiar ^a   Mikkelsen, Tom ^b   Diglio, Clement A ^a   Sloane, Bonnie F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Lysosomes; Microvasculature, neovessels; Proteases; Tumor invasion

Indexed keywords

CATHEPSIN B;

ANIMAL; CANCER INVASION; CHEMISTRY; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CATHEPSIN B; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0030320775     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o96-086     Document Type: Article

References (3)

1. Alexander, C.M., Hansell, A.J., Behrendtsen, O., Flannery, M.L., Kishnani, N.S., Hawkes, S.P., and Werb, Z. 1996. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development (Cambr.), 122: 1723-1736.
2. Anisowicz, A., Sotiropoulou, G., Stenman, G., Mok, S.C., and Sager, R. 1996. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol. Med. In press.
3. Arkona, C., and Wiederanders, B. 1996. Expression, subcellular distribution and plasma membrane binding of cathepsin B and gelatinases in bone metastatic tissue. Biol. Chem. 377: 695-702.